Dihydroberberine (GlucoVantage) vs PQQ (Pyrroloquinoline Quinone)

Mechanism

Active metabolite of berberine with 5x greater absorption. AMPK activator that improves insulin sensitivity, reduces hepatic glucose production, and modulates gut microbiome. More bioavailable form allows lower dosing with fewer GI side effects.

Contraindications

• Same as berberine — hypoglycemia risk with diabetic medications

Mechanism

PQQ activates PGC-1alpha via CREB phosphorylation, directly stimulating mitochondrial biogenesis — the formation of new mitochondria. It acts as a redox cycling agent capable of thousands of catalytic oxidation-reduction cycles (compared to ~4 for vitamin C), providing exceptional antioxidant capacity. PQQ also modulates NMDA receptor signaling and promotes nerve growth factor (NGF) synthesis, supporting neuronal health and cognitive function.

Standard Dosing

10-20mg daily

Timing

With breakfast. Can combine in same meal with CoQ10.

Cycle Duration

ongoing

Side Effects

• Rare: headache
• Mild GI discomfort at higher doses
• Insomnia if taken late

Contraindications

• Pregnancy/lactation (insufficient safety data)

Best Stacking Partners